221 related articles for article (PubMed ID: 15599890)
21. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.
Caimi G; Carollo C; Montana M; Iatrino R; Bondì B; Lo Presti R
Blood Purif; 2009; 27(2):194-8. PubMed ID: 19153478
[TBL] [Abstract][Full Text] [Related]
23. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter.
Neade T; Uribarri J
Semin Dial; 2008; 21(4):331-7. PubMed ID: 18573134
[TBL] [Abstract][Full Text] [Related]
24. The role of leukocyte-generated oxidants in left ventricular remodeling.
Penn MS
Am J Cardiol; 2008 May; 101(10A):30D-33D. PubMed ID: 18474271
[TBL] [Abstract][Full Text] [Related]
25. In vivo markers of oxidative stress and therapeutic interventions.
Tsimikas S
Am J Cardiol; 2008 May; 101(10A):34D-42D. PubMed ID: 18474272
[TBL] [Abstract][Full Text] [Related]
26. Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotype.
Witasp A; Nordfors L; Lindholm B; Stenvinkel P
J Ren Nutr; 2007 Jan; 17(1):17-22. PubMed ID: 17198927
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
28. Uric acid and oxidative stress: relative impact on cardiovascular risk?
Strazzullo P; Puig JG
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
[TBL] [Abstract][Full Text] [Related]
29. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
Pecoits-Filho R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
Kidney Int Suppl; 2003 May; (84):S172-6. PubMed ID: 12694338
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
Förstermann U
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
[TBL] [Abstract][Full Text] [Related]
31. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
Elahi MM; Flatman S; Matata BM
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
[TBL] [Abstract][Full Text] [Related]
32. [Effect of oxidative stress in patients with chronic renal failure].
González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress and nitric oxide deficiency in inflammation of chronic renal failure. Possible preventive role of L-arginine and multiple antioxidants.
Korish AA
Saudi Med J; 2009 Sep; 30(9):1150-7. PubMed ID: 19750259
[TBL] [Abstract][Full Text] [Related]
34. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis.
Stenvinkel P; Pecoits-Filho R; Lindholm B;
Semin Dial; 2005; 18(4):322-30. PubMed ID: 16076356
[TBL] [Abstract][Full Text] [Related]
35. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
[TBL] [Abstract][Full Text] [Related]
36. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
[TBL] [Abstract][Full Text] [Related]
37. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
Pashkow FJ; Watumull DG; Campbell CL
Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
[TBL] [Abstract][Full Text] [Related]
38. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
39. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
Bibi G; Green Y; Nagler RM
Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
[TBL] [Abstract][Full Text] [Related]
40. Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients.
Piroddi M; Depunzio I; Calabrese V; Mancuso C; Aisa CM; Binaglia L; Minelli A; Butterfield AD; Galli F
Amino Acids; 2007; 32(4):573-92. PubMed ID: 17356806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
